MAINTENANCE THERAPY
Clinical trials for MAINTENANCE THERAPY explained in plain language.
Never miss a new study
Get alerted when new MAINTENANCE THERAPY trials appear
Sign up with your email to follow new studies for MAINTENANCE THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep High-Risk nasopharyngeal cancer at bay
Disease control Recruiting nowThis phase 3 trial tests whether adding toripalimab (an immunotherapy) to capecitabine (a chemotherapy pill) as maintenance therapy works better than capecitabine alone for people with high-risk nasopharyngeal carcinoma. The study enrolls 264 adults aged 18-70 who have completed …
Matched conditions: MAINTENANCE THERAPY
Phase: PHASE3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New vaccine aims to keep leukemia in remission
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own leukemia cells to help prevent the cancer from coming back. It is for adults with acute myeloid leukemia who are in remission after chemotherapy. The vaccine is designed to train the immune system to recognize and …
Matched conditions: MAINTENANCE THERAPY
Phase: PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug combo aims to stop leukemia relapse after transplant
Disease control Recruiting nowThis study looks at whether menin inhibitors can help prevent leukemia from coming back in patients who have had a stem cell transplant. About 20 adults with certain genetic types of acute leukemia will take these drugs as maintenance therapy. Researchers will track how many pati…
Matched conditions: MAINTENANCE THERAPY
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug gilteritinib may beat standard therapy in preventing AML relapse after transplant
Disease control Recruiting nowThis Phase 3 trial tests whether the drug gilteritinib is better than sorafenib at keeping leukemia from coming back in patients with a specific gene mutation (FLT3-ITD) after a stem cell transplant. About 594 adults and teens will take one of the two pills daily for up to 2 year…
Matched conditions: MAINTENANCE THERAPY
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC